Amaia Erdozain Fernández-rekin lankidetzan egindako argitalpenak (15)

2023

  1. Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 348-365

2021

  1. Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment

    European Neuropsychopharmacology, Vol. 42, pp. 12-21

  2. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2019

  1. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex

    Journal of Psychopharmacology, Vol. 33, Núm. 2, pp. 244-249

  2. Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons

    Brain Structure and Function, Vol. 224, Núm. 3, pp. 1219-1244

2018

  1. Characterisation of spinophilin immunoreactivity in postmortem human brain homogenates

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 81, pp. 236-242

  2. Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions

    Neuropsychopharmacology, Vol. 43, Núm. 5, pp. 1041-1051

2015

  1. Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects

    Journal of Psychopharmacology, Vol. 29, Núm. 11, pp. 1137-1145

  2. The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects

    Addiction Biology, Vol. 20, Núm. 4, pp. 773-783

2014

  1. Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results

    Drug Design, Development and Therapy, Vol. 8, pp. 263-277

2012

  1. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain

    Biochemical Pharmacology, Vol. 83, Núm. 2, pp. 260-268

2009

  1. Implicación del sistema cannabinoide endógeno en el alcoholismo

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 11, Núm. 2, pp. 85-95

  2. ¿Es realmente el consumo de cannabis un factor de riesgo para la esquizofrenia?

    Norte de Salud Mental, Vol. 8, Núm. 34, pp. 23-33

2008

  1. Guanidine and 2-aminoimidazoline aromatic derivatives as α2-adrenoceptor antagonists. 2. Exploring alkyl linkers for new antidepressants

    Journal of Medicinal Chemistry, Vol. 51, Núm. 11, pp. 3304-3312

  2. Novel synthesis and pharmacological evaluation as α2-adrenoceptor ligands of O-phenylisouronium salts

    Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 17, pp. 8210-8217